Apricus Biosciences Announces Shareholder Update With New Focus as a Commercially-Driven Specialty Pharmaceutical Company

SAN DIEGO, Feb. 16, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (“Apricus Bio” or the “Company”) (Nasdaq:APRI) announced today a corporate update to address Company activities and expected near-term events.

MORE ON THIS TOPIC